Pursue Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.27M Sell
1,101
-203
-16% -$240K 0.68% 38
2026
Q2
$1.56M Sell
1,304
-824
-39% -$842K 0.88% 38
2026
Q1
$1.96M Sell
2,128
-8
-0.4% -$8.11K 1.17% 27
2025
Q4
$2.3M Buy
+2,136
New +$2.04M 1.12% 27
2025
Q1
– Sell
-579
Closed -$447K – 126
2024
Q4
$447K Buy
579
+168
+41% +$139K 0.26% 63
2024
Q3
$364K Buy
+411
New +$370K 0.2% 70
2022
Q2
– Sell
-91
Closed -$28.1K – 175
2022
Q1
$28.1K Buy
+91
New +$23.4K 0.01% 198

Other funds holding LLY

Pursue Wealth Partners's LLY Position: Q3 2026 in Review

Pursue Wealth Partners reduced its Eli Lilly (LLY) stake by 16% in Q3 2026, selling an estimated $240K and leaving 1,101 shares worth $1.27M. The position accounts for 0.68% of the portfolio, ranked #38.

Pursue Wealth Partners first reported a position in LLY in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.3M in Q4 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Pursue Wealth Partners held 1,101 shares of Eli Lilly worth $1.27M as of Q3 2026.
  • Pursue Wealth Partners sold 203 Eli Lilly shares in Q3 2026, an estimated $240K.
  • Eli Lilly made up 0.68% of Pursue Wealth Partners's portfolio in Q3 2026, its #38 holding.
  • Pursue Wealth Partners first reported a position in Eli Lilly in Q1 2022 and has held it in 7 quarters since.
  • Pursue Wealth Partners's Eli Lilly position peaked at $2.3M in Q4 2025.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Pursue Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.